Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACTA.L Regulatory News (ACTA)

  • There is currently no data for ACTA

Re Contract

7 Nov 2008 07:00

RNS Number : 6671H
Acta S.p.A.
07 November 2008
 



07 November 2008 

Acta S.p.A. 

Second Stage Development Contract Confirmation

Acta S.p.A. ("Acta" or the "Company"), the AIM-listed catalyst developer, is delighted to announced the continuation of its development contract with a major Asian manufacturer and Sumitomo Corporation, into the second stage of the programme.

This confirmation follows the successful completion of the first phase of the project, in which all technical milestones and deadlines were met. Acta is encouraged that, despite a reduction in research and development expenditure by the customer, as previously announced, the programme has continued into the second stage. The Company believes that this continuation represents a strong validation of the commercial potential of Acta's advanced catalyst technologies.

The second stage of the contract will commence immediately, and is scheduled to deliver revenues of approximately €500,000 over the next four months, in line with the Company's expectations. The scope of work encompasses detailed characterisation of Acta's unique catalyst technology, and the parties believe that the work being undertaken will benefit Acta's products across several key applications.

As announced at the time of the interim results, Acta will continue to focus its development efforts on near-term revenue opportunities with major industrial partners, and to reduce non-core costs where possible. These cost reductions are not expected to impact the Company's operational capability, and the continuation of the development programme will be managed from within the Company's current technical resources.

Paolo Bert, Chief Executive, commented: 

"We are very pleased to confirm the continuation of our development contract with one of the world's leading manufacturers and our partners, Sumitomo Corporation. This confirmation comes despite an economic downturn which has reduced investment programmes, and underpins our confidence in the core value of our technologies. The commercial relationship between the parties and their commitment to this development programme remains strong."

For further information please contact:

Acta S.p.A:

Paul Barritt, Chief Financial Officer

Tel: +44 (0) 20 7360 4900

Smithfield Consultants:

Katie Hunt / Will Henderson

Tel: +44 (0) 20 7903 0671

Numis:

Tel: +44 (0) 20 7260 1000

Nominated Advisor: Simon Blank

Corporate Broking: David Poutney / Alex Ham

Notes to Editors

About Acta 

Acta develops and manufactures unique patented catalysts which have been launched to the renewable energy, automotive, battery and industrial markets. Acta is also developing other commercial opportunities using its catalysts for industrial waste treatment.

Acta's catalysts and alkaline system know-how are at the heart of the Company's development of a new, high pressure water electrolyser technology which has demonstrated low cost, platinum free, high pressure hydrogen generation. Combined with a platinum free fuel cell, the system offers a solution to the problem of how to store surplus energy produced from large scale, intermittent renewable energy sources (eg wind farms).

Acta's catalysts are also undergoing customer tests in applications such as ammonia treatment (removal of ammonia from an industrial waste stream), and zinc-air batteries (a high performance and environmentally friendly battery technology), as well as fuel cell and other applications.

- Ends -

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTFKAKKOBDDODK
Date   Source Headline
10th Apr 20087:00 amRNSDirector/PDMR Shareholding
31st Mar 200811:01 amRNSTotal Voting Rights
28th Mar 200810:32 amRNSSecond Sumitomo Subscription
26th Mar 20087:00 amRNSAdditional Listing
19th Mar 20087:00 amRNSFinal Results
5th Mar 20088:32 amRNSJoint Collaboration Agreement
4th Mar 20087:00 amRNSNotice of Results
21st Feb 200810:15 amRNSMerger Update
1st Feb 20087:00 amRNSTotal Voting Rights
17th Jan 20087:01 amRNSTrading Statement
16th Jan 20087:00 amRNSDirector/PDMR Shareholding
3rd Jan 20087:00 amRNSDisposable Fuel Cell Sale
18th Dec 20079:59 amRNSCompletion of Merger
10th Dec 20077:00 amRNSDirector/PDMR Shareholding
7th Dec 20077:01 amRNSDirector/PDMR Shareholding
6th Dec 20077:00 amRNSDirector/PDMR Shareholding
30th Nov 20079:20 amRNSDirector/PDMR Shareholding
28th Nov 20077:00 amRNSMajor Development Contract
16th Nov 200712:02 pmRNSResult of EGM
12th Oct 200710:30 amRNSNotice of EGM
3rd Oct 20077:01 amRNSNew Corporate Website
28th Sep 20073:17 pmRNSTotal Voting Rights
28th Sep 200710:06 amRNSCompletion of Placing
26th Sep 200712:02 pmRNSAdditional Listing
19th Sep 20077:01 amRNSInterim Results
6th Sep 20072:58 pmRNSResult of EGM
5th Sep 20077:01 amRNSNotice of Results
10th Aug 20074:32 pmRNSAIM Rule 26
23rd Jul 200712:56 pmRNSNotice of EGM
19th Jul 20077:00 amRNSTrading Statement
13th Jul 200711:46 amRNSDirector/PDMR Shareholding
12th Jul 20079:44 amRNSDirector/PDMR Shareholding
12th Jul 20077:00 amRNSStrategic Investment
5th Jul 20077:01 amRNSDirector/PDMR Shareholding
31st May 20077:04 amRNSAGM Statement
15th May 20077:05 amRNSEthanol Fuel Cell Vehicle
10th May 20077:01 amRNSLaunch of New Catalyst
20th Mar 20077:01 amRNSStmt re. Carbon Trust Grant
20th Mar 20077:00 amRNSFinal Results
12th Mar 20077:02 amRNSNotice of Results
22nd Feb 20074:04 pmRNSAuto Fuel Cell Catalyst
21st Feb 20077:02 amRNSAuto Fuel Cell Catalyst
19th Jan 20077:00 amRNSTrading Statement
21st Dec 20063:10 pmRNSTotal Voting Rights
19th Dec 20067:01 amRNSDirectorate Change
13th Dec 20067:01 amRNSEuropean Patent Granted
21st Sep 20067:01 amRNSInterim Results
13th Sep 20067:01 amRNSExtension of Relationship
7th Sep 20067:01 amRNSManagement Appointment
4th Sep 20063:45 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.